-
MODELLING THE FINANCIAL IMPACT OF SUPERSATURATED OXYGEN THERAPY AFTER PRIMARY PCI: A HOSPITAL PERSPECTIVE
Mar 18, 2026, 21:38 PM -
REDESIGNING MUSCULOSKELETAL REFERRAL PATHWAYS IN EUROPE: SYSTEM-LEVEL EFFECTS OF A DIGITAL-SEROLOGY TRIAGE MODEL
Mar 18, 2026, 21:38 PM -
PREDICTORS AND OUTCOMES OF SURGERY IN PATIENTS WITH STAGE IV BREAST CANCER: INVASIVE DUCTAL CARCINOMA VERSUS INVASIVE LOBULAR CARCINOMA
Mar 18, 2026, 21:38 PM -
GASTROINTESTINAL TOLERANCE, MALNUTRITION, AND HEALTHCARE RESOURCE UTILIZATION ARE IMPACTED IN PEDIATRIC AND ADULT OUTPATIENTS USING A PEA PEPTIDE ENTERAL FORMULA
Mar 18, 2026, 21:38 PM -
MANAGEMENT BASED ON THE INSTITUTIONALIZATION OF HEALTH TECHNOLOGY ASSESSMENT (HTA): THE CASE OF THE ETONOGESTREL SUBDERMAL IMPLANT IN A BRAZILIAN PRIVATE HEALTH INSURANCE
Mar 18, 2026, 21:38 PM -
CONTEXT-AWARE GENERATIVE AI FOR EVIDENCE GENERATION, ANALOG-DRIVEN ENROLLMENT FORECASTING, AND OPERATIONAL RISK MANAGEMENT IN ONCOLOGY TRIALS
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING LOBECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
MODELING APPROACHES FOR VACCINE INDIRECT EFFECTS IN ECONOMIC EVALUATIONS: A SCOPING REVIEW OF PUBLISHED REVIEWS AND METHODOLOGICAL GUIDANCE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND POTENTIAL VALUE OF T-REGULATORY CELL THERAPY IN THE TREATMENT OF MODERATE-SEVERE CROHN’S DISEASE
Mar 18, 2026, 21:38 PM -
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Mar 18, 2026, 21:38 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM -
A MODELING STUDY INVESTIGATING THE POTENTIAL OF MULTI-CANCER EARLY DETECTION SCREENING IN REDUCING CANCER INCIDENCE AND MORTALITY IN HIGH-RISK GROUPS
Mar 18, 2026, 21:38 PM -
PREDICTORS OF GLP-1 RECEPTOR AGONIST USE AMONG U.S. ADULTS WITH COMORBID DEPRESSION AND TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF SIMPLIFIED DOSING TERMINOLOGY ON TREATMENT EXPOSURE AND BUSGET IMPACT ESTIMATES
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
CHARACTERIZING AGE-RELATED PATTERNS IN HEALTHCARE COSTS AND UTILIZATION AMONG PEOPLE LIVING WITH ANGELMAN SYNDROME IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH LONGITUDINAL TRAJECTORIES OF HYDROXYUREA ADHERENCE AMONG INDIVIDUALS WITH SICKLE CELL DISEASE: A GROUP-BASED TRAJECTORY MODELING STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF RIBOCICLIB PLUS ENDOCRINE THERAPY (ET) VERSUS ABEMACICLIB PLUS ET IN THE ADJUVANT TREATMENT OF NODE POSITIVE PRE AND POSTMENOPAUSAL WOMEN WITH HR+/HER2- EARLY BREAST CANCER (EBC): A CANADIAN PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM
